These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24943516)

  • 1. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    Thromb Haemost; 2015 Aug; 114(3):537-45. PubMed ID: 25948492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a 'pendulum effect' drug using a nationwide database.
    Tagami T
    J Thromb Haemost; 2018 Mar; 16(3):458-461. PubMed ID: 29316251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.
    Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
    BMC Cancer; 2020 Sep; 20(1):867. PubMed ID: 32907555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
    Hayakawa M; Kudo D; Saito S; Uchino S; Yamakawa K; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
    Shock; 2016 Dec; 46(6):623-631. PubMed ID: 27548460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: comment.
    Aota T; Matsumoto T; Suzuki K; Imai H; Katayama N; Wada H
    J Thromb Haemost; 2015 Apr; 13(4):679-80. PubMed ID: 25528989
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: reply.
    Tagami T; Matsui H; Yasunaga H
    J Thromb Haemost; 2015 Apr; 13(4):680-2. PubMed ID: 25530550
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study.
    Umemura Y; Yamakawa K; Hayakawa M; Kudo D; Fujimi S
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):734-740. PubMed ID: 29471674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Human Soluble Thrombomodulin Contributes to a Reduction In-Hospital Mortality of Acute Cholangitis with Disseminated Intravascular Coagulation: A Propensity Score Analyses of a Japanese Nationwide Database.
    Tarasawa K; Fujimori K; Fushimi K
    Tohoku J Exp Med; 2020 Sep; 252(1):53-61. PubMed ID: 32879147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers.
    Iba T
    J Thromb Haemost; 2015 Apr; 13(4):682-3. PubMed ID: 25611174
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers.
    Wada H; Aota T; Matsumoto T; Suzuki K; Imai H; Katayama N
    J Thromb Haemost; 2015 Apr; 13(4):684-5. PubMed ID: 25611679
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: reply to two papers.
    Tagami T; Matsui H; Yasunaga H
    J Thromb Haemost; 2015 Apr; 13(4):686-8. PubMed ID: 25650788
    [No Abstract]   [Full Text] [Related]  

  • 15. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Saitoh D; Gando S; Thachil J
    Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
    Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
    J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection.
    Choi Q; Hong KH; Kim JE; Kim HK
    Ann Lab Med; 2014 Mar; 34(2):85-91. PubMed ID: 24624342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
    Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
    Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
    Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.
    Yamakawa K; Umemura Y; Hayakawa M; Kudo D; Sanui M; Takahashi H; Yoshikawa Y; Hamasaki T; Fujimi S;
    Crit Care; 2016 Jul; 20(1):229. PubMed ID: 27472991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.